Boxer Capital

Boxer Capital

Boxer Capital

Tavistock Group is an international private investment organization founded by Joe Lewis more than 40 years ago and built on a core philosophy: We strive for excellence in everything we do.
Follow us
$50,000,000 Venture capital (Series A)
FinSMEs

Tyra Biosciences Raises USD 50M in Series A Funding

the home of AI info

Global Superoxide Dismutase [Cu-Zn] Market 2016-2026 | AveXis Inc, Ionis Pharmaceuticals Inc ...

Technical.ly Philly

University City biotech firm Cabaletta Bio Inc. goes public in $74.8M IPO

PE HUB

VC-backed Cabaletta Bio begins trading on NASDAQ

$113,800,000 IPO
PE HUB

Biopharma firm Atreca goes public

$50,000,000 Venture capital (Series B)
MedCity News , FinSMEs

Cabaletta Bio closes $50M Series B round for cell-based autoimmune disease therapies

FinSMEs

Sojournix Completes $44M Series C Financing

$80,000,000 Venture capital
FinSMEs

Milestone Pharmaceuticals Raises $80M in Equity Funding

Funding Health
$125,000,000 Venture capital (Series C)
FinSMEs , PE HUB , MedCity News

Atreca Raises $125M in Series C Funding

Funding
Xconomy

SMA Day: AveXis Gene Therapy Creeps Forward as Biogen Drug’s Sales Slow

Health Science
Bloomberg , Xconomy

Novartis to Buy AveXis in $8.7 Billion Gene-Therapy Deal

Health
$30,500,000 Venture capital (Series B)
PE HUB , FinSMEs , Venture Funding News

Poseida Therapeutics snags $30.5 mln Series B

Messaging
$94,000,000 Venture capital (Series B)
FinSMEs

Ideaya Biosciences Raises $94M Crossover Series B Financing

Funding
$75,000,000 Venture capital (Series A)
Xconomy , FinSMEs

Prevail Gets $75M For Parkinson’s Gene Therapy, Bolstering NY Biotech

Health Funding Science
$35,000,000 Venture capital (Series B)
PE HUB , PE HUB

Atreca raises $35 mln Series B co-led by Wellington

Funding
$40,000,000 Venture capital (Series A)
prnewswire

CiVi Biopharma Raises $40 Million in Series A Financing From Boxer Capital of the Tavistock Group

$10,000,000 Venture capital (Series C)
VentureWire , FinSMEs

Gene Therapy Company AveXis Closes $10M Series C